Vaccine money incentive quotes
Medical control ploys Vaccine quotes
"Developed by Chiron (Emeryville, CA), the hepatitis B vaccine--which racked up over $2 billion in worldwide sales last year--was licensed to Merck (Whitehouse Station, NJ), which subsequently licensed it to SmithKline Beecham (SKB, Philadelphia, PA). Biogen (Cambridge, MA) also played a role in developing the product and still receives royalties on its sales from both Merck and SKB, as does Chiron."--BJ Spalding http://www.biospace.com/articles/111199_print.cfm[Feb 2008] The report predicts that due to the "promising commercial potential" of new, high-price vaccines, the pediatric and adolescent market will quadruple from approximately $4.3 billion in 2006, to over $16 billion by 2016, across the US, the EU-five including France, Germany, Italy, Spain, and the UK, and Japan.
[Nov 2006] Based on an average patient list of 5,000 people, if 70 per cent of under-twos have ALL their jabs the practice gets a £2,655 bonus. But if 90 per cent of toddlers are fully immunised the bonus rockets to £7,965. Surgeries are paid another £822 if 70 per cent of under-fives have all their jabs. If 90 per cent of under-fives do this. then the practice gets a bonus of £2,465. And if fewer than 70 per cent of children are vaccinated, then doctors get nothing. http://www.thesun.co.uk/sol/homepage/news/article70331.ece
"Vaccinations are now carried out for purely commercial reasons because they fetch huge profits for the pharmaceutical industry......There is no scientific evidence that vaccinations are of any benefit, but it is clear that they cause a great deal of harm."---Dr Buchwald (The Decline of Tuberculosis despite "Protective" Vaccination by Dr. Gerhard Buchwald M.D. p130, 132, 134.)
"Controlling for inflation, the cost of vaccine purchase per child climbed from $10 in 1975 to $385 in 2001. The cost of vaccine purchase in the year 2020 following recommendation of 7 additional vaccines is estimated to be $1225 per child (95% confidence interval = $891, $1559)."---Dec 2002 American Journal of Public Health
"GlaxoSmithKline Plc and Aventis Pasteur, who both claim a 24-percent share of the $6.5 billion-a-year global vaccine market, said demand was being driven by new products, including combination jabs and new adult treatments. The infant sector currently accounts for two-thirds of vaccine sales but market dynamics are changing, helped by growing demand for flu shots among the elderly and increased use of vaccines by tourists visiting tropical countries.......global vaccine sales would rise by more than a fifth to about $8 billion by 2005, underlying a long-term trend which has seen a tenfold increase in sales since 1980, while drug sales have risen only five times. ....Both GSK and Aventis expect to clock up vaccine sales of around $1.6 billion this year....Adrian Howd, biotechnology analyst at ABN AMRO, said vaccines were now one of the fastest-growing areas of healthcare, with demand for new products outweighing supply, and the total market set to top $10 billion by 2010."--Media 2002
"There are 25,000 of
us in the United Kingdom, and we stick together more closely than any other
profession. You may take the Law or the Church, and you will find in neither
the same intense devotion to corporate interests. If one makes a mistake, the
others are ready to hide it. Many coroners are medical men, and when a case
occurs that is not favourable to the profession, it is more or less dexterously
slurred over. By means of this trade unionism we have acquired immense power,
which is yearly increasing. Law and Church will soon be accounted second and
third. People cannot be born without us; they cannot die without us; and it
will come to pass that they cannot be married or take a situation without us.
All this tends to make the medical profession pretty unanimous on a question
which is supposed to be one of its Articles of Faith.
..........And then the money we make out of it! .......Seeing how it pays, you certainly must not go to the parties paid for disinterested advice. If you want the truth on vaccination you must to those who are not making anything out of it. If doctors shot at the moon every time it was full as a preventive of measles and got a shilling for it, they would bring statistics to prove it was a most efficient practice, and that the population would be decimated if it were stopped. They are bred in the faith that vaccination is a preventive of small-pox, and go on to practise it and to live by it. Be fair, therefore, to the doctors, and ask yourselves whether you would not believe as they do, and act as they do, if your training and interest coincided with theirs. We believe our teachers. I never heard of anti-vaccinators except as fools and fanatics, whose existence was marvellous. The only knowledge of vaccination I had was from a medical lecture explaining the nature of the process and the usual effects that follow it."---Dr Allinson 1883 http://www.whale.to/vaccines/smallpox20.html
"In calendar year 1999, the US federal government purchased approximately $600,000,000.00 worth of vaccine. This amount has generally represented one-half of the monetary outlay of vaccine in the U.S. Therefore, the total amount spent on childhood vaccines is approximately $1,200,000,000.00 annually in the U.S."--CDC (2000)
"Targeting patients for pneumococcal vaccination would mean immunising 5% and would bring in around £3,000."--Pulse article
"As far as Im concerned, tetanus is not an infectious disease characterised by muscle spasm but a bottomless pit of item-of-service cash."--Pulse letter
"This practice could generate up to £3,700 from an effective annual influenza vaccination campaign if it immunised 10% of the practice."--Pulse article
Chicago: "In addition, the Department provides local health departments and other public health providers with incentive payments for completing the vaccine series for 2-year-olds. The Department pays $10 for each child fully immunized. If the local health department or public clinics achieves full coverage for 90 percent of the children they serve, the per-child payment is boosted to $15. " "Since 1994, the Department has paid $5.3 million in incentives, including an estimated $1.6 million since July 1996."http://www.idph.state.il.us/public/press97/immunize.htm
"One vaccine against smallpox costs about 600DM and the proclaimed target is to vaccinate 3 billion people...Vaccination is a huge business for the pharmaceutical industry....All the other forms of hepatitis we didnt vaccinate against were in decline. But hepatitis B stayed at the same level, even after the introduction of the vaccine. It was then believed in Germany that we made a mistake, its not being passed through the blood but by sexual contact. We expected the response to be to vaccinate everyone where the event of sexual intercourse would be a factor... However, the response was to vaccinate everyone. And this is where you can see that it all revolves around money."--Dr Buchwald MD
"TO ENCOURAGE HIGH VACCINATION RATES, FEDERAL OFFICIALS GIVE GRANTS and other financial incentives to state health and education agencies, or withhold them. In 1993, the Clinton administration launched an Immunization Initiative, and Congress authorized more than $400 million for states that enforced mandatory vaccination by using social security numbers to track children from birth. Simultaneously, a grant program rewards state health departments with up to $100 for each fully vaccinated child.."----Barbara Loe Fisher
GSKs Vaccines business is also contributing to both the short and long term prospects of the company through a strong pipeline of new products. In the short-term, growth will be boosted by the launch this year of Infanrix PeNta in the US, as well as Twinrix for adults, the first and only vaccine that protects against hepatitis A and B. GSK has a wealth of late stage development products: for example, a pediatric combination vaccine against meningitis A and C, set to be launched into a market with a $500 million potential; as well as a second generation vaccine against S. pneumoniae and a vaccine against rotavirus, each directed at a $1 billion market. Exciting long-term opportunities include the search for vaccines for global challenges such as HIV and malaria, and the creation of a new generation of therapeutic vaccines."--SOURCE: GlaxoSmithKline plc
"What have GPs been saying about the new (meningitis) vaccine? They mostly seem to be worried that the new vaccine is going to be introduced without the Department of Healths paying them any extra money for giving it. Certainly, there have been many more pages devoted to the financial implications to GPs than there have to the safety profile to recipients."--Dr Jayne Donegan
"If you want the truth on vaccination you must go to those who are not making anything out of it. If doctors shot at the moon every time it was full as a preventive of measles and got a shilling for it, they would bring statistics to prove it was a most efficient practice, and that the population would be decimated if it were stopped."---Dr Allinson
"Vaccination is expensive and represents a cost of one billion dollars annually. It therefore benefits the industry; most notably, the multinational manufacturers. One sells the vaccines. The other then provides the arsenal of medications to respond to the numerous complications that follow. Their profits increase while our expenses go through the roof."---Lanctot, M.D.
"We suspect financial ties between vaccine manufacturers and medical groups such as the American Medical Association and American Academy of Pediatrics (AAP) which endorse the (hep B) vaccine," says Dr. Orient, pointing to a substantial donation to AAP from Merck & Co. "And the federal government pays the state a bonus up to $100 for every "fully" vaccinated child. Whats their motive -- money or medicine?"---Jane Orient M.D.
"The pharmaceutical business is so attractive that it's a wonder we don't hear its praises sung more often. Airplanes should circle the planet dropping leaflets: "Forget about investing in Coca-Cola (NYSE: KO). Invest in leading pharmaceutical companies." The reasons for ebullience are many. Coca-Cola is often heralded as a repeat-purchase business. True, it is, but only as long as people want to keep drinking Coke. Pharmaceuticals are better than that. The chronic nature of many diseases means that a majority of medications are anything but a one-time sale. When a patient is placed on medication, it's often a prescription taken for several years, even lifelong. Remember "take your medicine"? Repeat business leads to reliable earnings at pharmaceutical companies, because each new patient represents an annuity revenue stream. Five Reasons to Look at Pharmaceutical Stocks: Pharmaceutical companies offer unique opportunities for investors. As the Baby Boomers age, more people must regularly buy high-margin prescription drugs. New biotechnologies move more and better drug treatments through afaster FDA approval process. And, managed care relies on medicines to savemoney on health care costs. This industry demands an investor's attention."--The Motley Fool http://www.fool.com
"Selling vaccines is extremely profitable and the
process of mandating vaccines is fraught with conflicts of interest between vaccine
manufacturers, the ACIP and the American Academy of Pediatrics. The business model of
having the government mandate everyone must buy your product is a monopolists
delight ."---Michale Belkin
MICHAEL BELKIN'S WRITTEN TESTIMONY TO CONGRESS
"Meanwhile, manufacturers' profits have risen as the average cost to fully immunize a child at a private physician's office has climbed 243% since 1986, from $107 to $367. The most prominent beneficiaries have been the two producers who dominate the U.S. market for DPT and polio vaccines, Connaught Laboratories ($300 million in U.S. sales last year) and Wyeth-Lederle Vaccines & Pediatrics ($350 million). U.S. revenues for both companies have increased 300% since 1986, estimates David Molowa, international pharmaceutical analyst at the Wall Street investment firm Bear Stearns."--Money Magazine http://www.geocities.com/Heartland/Flats/6997/money.html
News (Daily Express sept 13, 1999) Greedy GP's vaccine ploy. Doctors axing patients to profit over controversial jab, says Royal Society of Medicine report (author Dr Neena Buntwal).
"The difficulties parents face in getting compensation contrasts with the treatment of doctors. They get £1,800 if 90% of the children under two are vaccinated. If only 70%, they get £600. Below this they get no bonus. The Fletchers believe these payments threaten the objectivity of medical decisions."--Jani Allen http://www.gn.apc.org/inquirer/jabs.html
Annual and long-term incentive plans have grown increasingly common in the health care industry. There are a number of reasons why Boards of hospitals and health care systems decide to provide incentive pay for executives and directors. The most common are: "pediatric immunization rates" http://www.healthcarecomp.com/top_nav_links/incentives/incentives0.htm
Hillman, A. L., K. Ripley, N. Goldfarb, J. Weiner, I. Nuamah and E. Lusk.
"The use of physician financial incentives and feedback to improve pediatric preventive care in Medicaid managed care." Pediatrics. 104(4 Pt 1): 931-5. 1999.
Kouides, R. W., B. Lewis, N. M. Bennett, K. M. Bell, W. H. Barker, E. R.
Black, J. D. Cappuccio, R. F. Raubertas and F. M. LaForce. "A performance-based incentive program for influenza immunization in the elderly." American Journal of Preventive Medicine. 9(4): 250-254. 1993.
"Hillman (1996) analyzed the effect of audit and feedback alone, and audit and feedback combined with financial incentives on provider compliance with pediatric preventive care guidelines, including immunizations. The settings were 53 primary care practice sites in one city, each site having at least 25 pediatric patients. " http://www.ambpeds.org/imm.html
Morrow R., Gooding A., and Clark C. Improving physicians' preventive health care behavior through peer review and financial incentives. Archives of Family Medicine 1995;4 (2): 165-169. http://www.ambpeds.org/imm.html